Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1832494, 9 pages
https://doi.org/10.1155/2017/1832494
Research Article

Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway

1Department of Radiation Oncology, Affiliated People’s Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, China
2School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China

Correspondence should be addressed to Chaoyang Wu; moc.qq@96532061

Received 6 April 2017; Revised 16 September 2017; Accepted 24 September 2017; Published 26 October 2017

Academic Editor: Sung-Hoon Kim

Copyright © 2017 Gang Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. F. Altekruse, K. A. McGlynn, and M. E. Reichman, “Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005,” Journal of Clinical Oncology, vol. 27, no. 9, pp. 1485–1491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kalyan, H. Nimeiri, and L. Kulik, “Systemic therapy of hepatocellular carcinoma: current and promising,” Clinics in Liver Disease, vol. 19, no. 2, pp. 421–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Abrams and J. W. Marsh, “Current approach to hepatocellular carcinoma,” Surgical Clinics of North America, vol. 90, no. 4, pp. 803–816, 2010. View at Google Scholar
  4. A. Forner, J. M. Llovet, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 379, no. 9822, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Sharma, “Role of external beam radiation therapy in management of hepatocellular carcinoma,” Journal of Clinical and Experimental Hepatology, vol. 4, supplement 3, pp. S122–S125, 2014. View at Publisher · View at Google Scholar
  6. W. Y. Lau and E. C. Lai, “Hepatocellular carcinoma: current management and recent advances,” Hepatobiliary & Pancreatic Diseases International, vol. 7, no. 3, pp. 237–257, 2008. View at Google Scholar
  7. B. Gao, H. Wang, F. Lafdil, and D. Feng, “STAT proteins - Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver,” Journal of Hepatology, vol. 57, no. 2, pp. 430–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Teng, J. L. Ross, and J. K. Cowell, “The involvement of JAK-STAT3 in cell motility, invasion, and metastasis,” JAK-STAT, vol. 3, no. 1, p. e28086, 2014. View at Publisher · View at Google Scholar
  9. J.-T. Kao, C.-L. Feng, C.-J. Yu et al., “IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: A cohort study,” BMC Gastroenterology, vol. 15, no. 1, 50 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Zhang, W.-D. Duan, J.-J. Leng et al., “STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma,” Oncology Reports, vol. 33, no. 3, pp. 1493–1498, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Subramaniam, M. K. Shanmugam, E. Perumal et al., “Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma,” Biochimica et Biophysica Acta, vol. 1835, no. 1, pp. 46–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-F. Yang, S.-N. Wang, C.-F. Wu et al., “Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma,” Journal of Clinical Pathology, vol. 60, no. 6, pp. 642–648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Wang, P. J. Crowe, D. Goldstein, and J.-L. Yang, “STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (Review),” International Journal of Oncology, vol. 41, no. 4, pp. 1181–1191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Schust, B. Sperl, A. Hollis, T. U. Mayer, and T. Berg, “Stattic: a small-molecule inhibitor of STAT3 activation and dimerization,” Chemistry & Biology, vol. 13, no. 11, pp. 1235–1242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Pan, F. Zhou, R. Zhang, and F. X. Claret, “Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma,” PLoS ONE, vol. 8, no. 1, Article ID e54565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Adachi, C. Cui, C. T. Dodge, M. K. Bhayani, and S. Y. Lai, “Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma,” Oral Oncology, vol. 48, no. 12, pp. 1220–1226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Spitzner, B. Roesler, C. Bielfeld et al., “STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo,” International Journal of Cancer, vol. 134, no. 4, pp. 997–1007, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Zhang, C. Zhang, J. He et al., “STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma,” Tumor Biology, vol. 36, no. 3, pp. 2135–2142, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Tsukamoto, K. Shibata, H. Kajiyama, M. Terauchi, A. Nawa, and F. Kikkawa, “Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells,” Gynecologic Oncology, vol. 107, no. 3, pp. 500–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-C. Zhou, J.-Y. Liu, J. Li et al., “Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition,” International Journal of Radiation Oncology • Biology • Physics, vol. 81, no. 5, pp. 1530–1537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Colomiere, A. C. Ward, C. Riley et al., “Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas,” British Journal of Cancer, vol. 100, no. 1, pp. 134–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-W. Lo, S.-C. Hsu, W. Xia et al., “Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression,” Cancer Research, vol. 67, no. 19, pp. 9066–9076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-N. Ho, G. Y. Kang, S.-S. Lee et al., “Bcl-XL and STAT3 mediate malignant actions of γ-irradiation in lung cancer cells,” Cancer Science, vol. 101, no. 6, pp. 1417–1423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K.-W. Hsu, R.-H. Hsieh, K.-H. Huang et al., “Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression,” Carcinogenesis, vol. 33, no. 8, pp. 1459–1467, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Tu, L. Du, Q.-M. Fan, Z. Tang, and T.-T. Tang, “STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma,” Cancer Letters, vol. 325, no. 1, pp. 80–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. W. Kim, R. W. Mutter, C. Cao et al., “Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation,” Molecular Cancer Therapeutics, vol. 5, no. 11, pp. 2659–2665, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Bonner, H. Q. Trummell, C. D. Willey, B. A. Plants, and K. P. Raisch, “Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma,” Radiotherapy & Oncology, vol. 92, no. 3, pp. 339–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Gao, Y. Cong, F. Li et al., “Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells,” International Journal of Radiation Oncology • Biology • Physics, vol. 77, no. 4, pp. 1223–1231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-W. Chen, K.-H. Chen, P.-I. Huang et al., “Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44+ALDH1+ cells,” Molecular Cancer Therapeutics, vol. 9, no. 11, pp. 2879–2892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. K. Balcer-Kubiczek, “Apoptosis in radiation therapy: a double-edged sword,” Experimental Oncology, vol. 34, no. 3, pp. 277–285, 2012. View at Google Scholar · View at Scopus
  31. L. Liu, S. Nam, Y. Tian et al., “6-Bromoindirubin-3-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells,” Cancer Research, vol. 71, no. 11, pp. 3972–3979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Zhu, E. Li, Y. Liu et al., “Inhibition of Jak-STAT3 pathway enhances Bufalin-induced apoptosis in colon cancer SW620 cells,” World Journal of Surgical Oncology, vol. 10, 228 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Lu, J. Wang, T. Zheng et al., “FTY720 inhibits proliferation and epithelialmesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling,” BMC Cancer, vol. 14, no. 1, 783 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus